Associated Papers
Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies.
Palumbo E et al.
Journal of Biomolecular Structure & Dynamics, 2020
31232187 (PubMed )
Supplement: supplement_1.zip › Supplement_S4_mutants_nochange.xlsx › Mutants_no_change
A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma.
Cimmino F et al.
Frontiers in Oncology, 2020
33381456 (PubMed )
Supplement: DataSheet_1.xlsx › Supplementary_Table_3
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
Kim HR et al.
Lung Cancer (amsterdam, Netherlands), 2014
Comprehensive analysis of PTEN status in Sezary syndrome.
Cristofoletti C et al.
Blood, 2013
Functional definition of relevant epitopes on the tumor suppressor PTEN protein.
Andrés-Pons A et al.
Cancer Letters, 2005
Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions.
Torres J et al.
The Journal of Biological Chemistry, 2003
Select a paper to view details